Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Immunoglobulins/Rituximab/Steroids

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cekic-Hajdarpasic S, et al. Heavy Menstrual Bleeding in Paediatric Patient due to Resistant Chronic Immune Thrombocytopenia Successfully Treated with Eltrombopag and Tranexemic Acid - a Case Report Form Bosnia and Herzegovina. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): abstr. PB0367, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.rpth.2023.101496 [abstract] Cekic-Hajdarpasic S, et al. Heavy Menstrual Bleeding in Paediatric Patient due to Resistant Chronic Immune Thrombocytopenia Successfully Treated with Eltrombopag and Tranexemic Acid - a Case Report Form Bosnia and Herzegovina. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): abstr. PB0367, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​rpth.​2023.​101496 [abstract]
Metadaten
Titel
Immunoglobulins/Rituximab/Steroids
Lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54107-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Factor-IX

Case report

Multiple drugs

Case report

Pembrolizumab